David S Schladt

5PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Respiratory diseasesWastewater treatment processesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 02, 2024
Randomized Controlled Trial to Evaluate a New Tool to Support Patient Decision-making on Transplant Centers.

Warren T McKinney, Kareena Israni, Cory R Schaffhausen

|Aug 23, 2024
Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients.

Moataz E Mohamed, Bin Guo, Baolin Wu

|May 31, 2024
Polygenic risk score for acute rejection based on donor-recipient non-HLA genotype mismatch.

Rui Cao, David P Schladt, Casey Dorr

|Dec 26, 2022
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers.

Kevin A Reininger, Guillaume Onyeaghala, Teresa Anderson-Haag

|Jul 15, 2020
Pharmacogenomics in kidney transplant recipients and potential for integration into practice.

Tam T Nguyen, Rachael A Pearson, Moataz E Mohamed

Pageof 1

Frequent Collaborators

4 joint publications

Arthur Matas

3 joint publications

Ajay K Israni

3 joint publications

Pamala A Jacobson

3 joint publications

Roslyn Mannon